Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ravid

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Surgery, Gynecology & Obstetrics|December 1, 1993
The effect of heat load and dehydration on hypertonic saline solution treatment of controlled hemorrhagic shockM M Krausz, A Ravid, U Izhar, et al.
The Journal of Clinical Investigation|November 1, 1985
Defective binding and function of 1,25-dihydroxyvitamin D3 receptors in peripheral mononuclear cells of patients with end-organ resistance to 1,25-dihydroxyvitamin DR Koren, A Ravid, U A Liberman, et al.
Anticancer Research|November 1, 1996
Failure of thalidomide to inhibit tumor growth and angiogenesis in vivoM Gutman, A Szold, A Ravid, et al.
The Journal of Endocrinology|June 18, 2002
Vitamin D inhibits the activation of stress-activated protein kinases by physiological and environmental stresses in keratinocytesA Ravid, E Rubinstein, A Gamady, et al.
The Journal of Endocrinology|May 1, 1996
1,25-dihydroxyvitamin D3 increases the sensitivity of human renal carcinoma cells to tumor necrosis factor alpha but not to interferon alpha or lymphokine-activated killer cellsR Yacobi, R Koren, U A Liberman, et al.
International Journal of Immunopharmacology|April 1, 1993
Foreign body granulomatous inflammation increases the sensitivity of splenocytes to immunomodulation by 1,25-dihydroxyvitamin D3I Ben Dror, R Koren, U A Liberman, et al.
Endocrinology|December 1, 1994
1,25-Dihydroxyvitamin D3 increases the cellular content of the calcium-activated neutral protease mu-calpain in renal cell carcinomaA Ravid, R Koren, C Rotem, et al.
Cancer Research|March 14, 2001
Vitamin D is a prooxidant in breast cancer cellsR Koren, I Hadari-Naor, E Zuck, et al.
The British Journal of Dermatology|February 17, 1999
Upregulation of the calcium-dependent protease, calpain, during keratinocyte differentiationO Garach-Jehoshua, A Ravid, U A Liberman, et al.
Cancer Immunology, Immunotherapy : CII|December 1, 1996
Increased microvascular permeability induced by prolonged interleukin-2 administration is attenuated by the oxygen-free-radical scavenger dimethylthioureaM Gutman, R Laufer, A Eisenthal, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Surgery, Gynecology & Obstetrics|December 1, 1993
The effect of heat load and dehydration on hypertonic saline solution treatment of controlled hemorrhagic shockM M Krausz, A Ravid, U Izhar, et al.
The Journal of Clinical Investigation|November 1, 1985
Defective binding and function of 1,25-dihydroxyvitamin D3 receptors in peripheral mononuclear cells of patients with end-organ resistance to 1,25-dihydroxyvitamin DR Koren, A Ravid, U A Liberman, et al.
Anticancer Research|November 1, 1996
Failure of thalidomide to inhibit tumor growth and angiogenesis in vivoM Gutman, A Szold, A Ravid, et al.
The Journal of Endocrinology|June 18, 2002
Vitamin D inhibits the activation of stress-activated protein kinases by physiological and environmental stresses in keratinocytesA Ravid, E Rubinstein, A Gamady, et al.
The Journal of Endocrinology|May 1, 1996
1,25-dihydroxyvitamin D3 increases the sensitivity of human renal carcinoma cells to tumor necrosis factor alpha but not to interferon alpha or lymphokine-activated killer cellsR Yacobi, R Koren, U A Liberman, et al.
International Journal of Immunopharmacology|April 1, 1993
Foreign body granulomatous inflammation increases the sensitivity of splenocytes to immunomodulation by 1,25-dihydroxyvitamin D3I Ben Dror, R Koren, U A Liberman, et al.
Endocrinology|December 1, 1994
1,25-Dihydroxyvitamin D3 increases the cellular content of the calcium-activated neutral protease mu-calpain in renal cell carcinomaA Ravid, R Koren, C Rotem, et al.
Cancer Research|March 14, 2001
Vitamin D is a prooxidant in breast cancer cellsR Koren, I Hadari-Naor, E Zuck, et al.
The British Journal of Dermatology|February 17, 1999
Upregulation of the calcium-dependent protease, calpain, during keratinocyte differentiationO Garach-Jehoshua, A Ravid, U A Liberman, et al.
Cancer Immunology, Immunotherapy : CII|December 1, 1996
Increased microvascular permeability induced by prolonged interleukin-2 administration is attenuated by the oxygen-free-radical scavenger dimethylthioureaM Gutman, R Laufer, A Eisenthal, et al.
Pageof 7